TICAROS Co., Ltd
PrivateLast Round
Series D
Mar 3, 2026
Est. Valuation
$197.42M
Total Funding Raised
$42.5M
Company Overview
TICAROS Co., Ltd is a biotechnology company that develops next-generation CAR-T and CAR-NK cell therapies for cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TICAROS Co., Ltd Comparables
Compare TICAROS Co., Ltd with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| InnoBation Bio | 83% | |
| Curocell | 81% | |
| AbClon Inc. | 78% |
TICAROS Co., Ltd Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Mar 3, 2026 | ||||
| Series C | Aug 24, 2021 | ||||
| Series B | Jan 9, 2020 | ||||
| Series A | Feb 1, 2019 |
TICAROS Co., Ltd Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KIWOOM Securities Co., Ltd. | Series D |
| Shinhan Venture Investment | Series C |
| iM Investment Partners | Series D |
| Kingo Investment Partners | Series C |
| UTC Investment | Series C |
| Medici Investment | Series C |
| Daesung Private Equity | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 9, 2020
$5.24M round led by Medytox Venture Investment.
TICAROS Co., Ltd Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about TICAROS Co., Ltd's valuation, stock price, and market status.
Is TICAROS Co., Ltd a public or private company?
TICAROS Co., Ltd is a private company.
What is the current stock price of TICAROS Co., Ltd?
TICAROS Co., Ltd is a private company with no public stock price. No recent secondary market data is available.
How much is TICAROS Co., Ltd worth (valuation)?
Valuation information for TICAROS Co., Ltd is not publicly available.
Can I buy TICAROS Co., Ltd stock?
TICAROS Co., Ltd shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was TICAROS Co., Ltd's last funding round?
TICAROS Co., Ltd's most recent funding round was Series D on March 9, 2026.
Who are the main investors in TICAROS Co., Ltd?
Key investors in TICAROS Co., Ltd include Medytox Venture Investment.
Will TICAROS Co., Ltd IPO soon?
No public IPO plans have been announced for TICAROS Co., Ltd.
How can I track TICAROS Co., Ltd secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor TICAROS Co., Ltd's secondary market activity and sign up for updates.